Eris Lifesciences on Friday said its consolidated profit after tax declined by 4.5 per cent year on year to Rs 89 crore for the quarter ended on June 30, 2024. The drug maker had reported a profit after tax of Rs 94 crore in the April-June quarter of the last fiscal.
